| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0360-3016(82)90307-8 |
| P698 | PubMed publication ID | 7153093 |
| P50 | author | Lester J. Peters | Q112452630 |
| Howard D. Thames | Q125119054 | ||
| P2093 | author name string | G H Fletcher | |
| H R Withers | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1807-1809 | |
| P577 | publication date | 1982-10-01 | |
| P1433 | published in | International Journal of Radiation Oncology Biology Physics | Q2296252 |
| P1476 | title | Hyperfractionation | |
| P478 | volume | 8 |
| Q71223810 | A new isoeffect curve for change in dose per fraction |
| Q36923435 | Accelerated hyperfractionation plus temozolomide in glioblastoma |
| Q70686642 | Acute reactions in rat feet exposed to multiple fractions of X-rays per day |
| Q48592727 | Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I/II study |
| Q48421519 | Continuous hyperfractionated accelerated radiotherapy in the treatment of high-grade astrocytomas |
| Q70686635 | Dose-response curve and split-dose recovery in human skin cancer |
| Q52077231 | Dynamic optimization of a linear-quadratic model with incomplete repair and volume-dependent sensitivity and repopulation. |
| Q79812044 | Early experience with a hybrid accelerated radiotherapy schedule for locally advanced head and neck cancer |
| Q36441529 | High dose hyperfractionated radiotherapy in the treatment of extremity soft tissue sarcomas |
| Q36673997 | Hyper-fractionated radiotherapy for soft tissue sarcoma: results of the second study of hyper-fractionated radiotherapy |
| Q39229582 | Hyperfractionated radiotherapy and polychemotherapy in brain stem tumors in children |
| Q32088985 | Hyperfractionated radiotherapy in head and neck cancer: a second look at the clinical data |
| Q55478814 | Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials. |
| Q41482096 | Hyperfractionation: where do we stand? |
| Q74336029 | Hyperfractionation: where do we stand? |
| Q34239497 | Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study |
| Q74114934 | Influence of dose per fraction and overall treatment time on the response of pulmonary micrometastases of the R1H-tumour to fractionated irradiation |
| Q33757638 | Issues in the management of nasopharyngeal carcinoma |
| Q70078853 | Late results of multiple fractions per day (MFD) with misonidazole in advanced cancer of the head and neck. A pilot study of the EORTC radiotherapy group |
| Q48632169 | Misonidazole combined with hyperfractionation in the management of malignant glioma |
| Q70686555 | Multiple small fractions per day versus conventional fractionation. Comparison of normal tissue reactions and effect on breast carcinoma |
| Q55484778 | Pediatric brainstem glioma. Post-radiation clinical and MR follow-up. |
| Q69529491 | Response of human tumour xenografts to fractionated X-irradiation |
| Q70497548 | The role of radiation in the treatment of cancer:radiobiologic and cell kinetic concepts |
| Q40727895 | The translational research chain: is it delivering the goods? |
| Q43694227 | Thyroid dysfunction as a late effect in childhood medulloblastoma: a comparison of hyperfractionated versus conventionally fractionated craniospinal radiotherapy |
| Q77537113 | [A linear quadratic analysis of the effect of different fractionation patterns on local tumor control: a study on human squamous-cell carcinomas in nude mice] |
Search more.